MAWET, M., Brichant, G., Thielen, V., Masson, V., & Chantraine, F. (April 2025). Kwashiorkor during pregnancy: A rare complication of bariatric surgery with fetal health consequences. European Journal of Obstetrics and Gynecology and Reproductive Biology, 307, 277 - 278. doi:10.1016/j.ejogrb.2025.02.003 |
Mawet, M., Evrevin, C., Dardenne, A., Kridelka, F., Pintiaux, A., & Chabbert-Buffet, N. (November 2024). Impact of hormonal contraception on endometrial histology in patients with Lynch syndrome, a retrospective pilot study. Familial Cancer, 23 (4), 523 - 529. doi:10.1007/s10689-024-00387-y |
Ledon, C., Mawet, M., Desreux, J., Kridelka, F., Chabbert Buffet, N., & Pintiaux, A. (September 2024). Cas clinique. Y a-t-il encore une place pour les modulateurs du récepteur de la progestérone en continu ? Revue Médicale de Liège, 79 (9), 554 - 558. |
Mawet, M., Basse, C., Barrois, M., Gligorov, J., Cadranel, J., Chabbert-Buffet, N., & Selleret, L. (December 2023). Second-trimester medical abortion after exposure to lorlatinib during early pregnancy, a case report. Journal of Gynecology Obstetrics and Human Reproduction, 52 (10), 102673. doi:10.1016/j.jogoh.2023.102673 |
HANOCQ, F., Kridelka, F., Mawet, M., THILLE, A., VALKENBORGH, C., Nechifor-Potorac, I., & Pintiaux, A. (January 2023). Comment j’explore … Le dosage hormonal étagé a-t-il une place dans la mise au point des hyperandrogénies ? Revue Médicale de Liège, 78 (1), 55 - 60. |
MAWET, M., Chabbert Buffet, N., Gerard, M., Nisolle, M., Kridelka, F., & Pintiaux, A. (September 2022). Nouveautés en contraception intra-utérine. Revue Médicale de Liège, 77 (9), 521 - 526. |
Mawet, M. (12 March 2022). Le Syndrome de HAIRAN, Une forme extrême des ovaires micro-polykystiques [Paper presentation]. Symposium du CRGOLFB. |
Perrier d'Hauterive, S., Close, R., Gridelet, V., Mawet, M., Nisolle, M., & Geenen, V. (25 January 2022). Human Chorionic Gonadotropin and Early Embryogenesis: Review. International Journal of Molecular Sciences, 23, 1380. doi:10.3390/ijms23031380 |
Mawet, M., NECHIFOR - POTORAC, I., BECKERS, A., KRIDELKA, F., & PINTIAUX, A. (December 2021). Comment j’explore…une hyperandrogénie dans un contexte d’insulinorésistance. Un exemple basé sur le syndrome HAIR-AN. Revue Médicale de Liège, 76 (12), 890-895. |
Klipping, C., Duijkers, I., Mawet, M., Maillard, C., Bastidas, A., Jost, M., & Foidart, J.-M. (April 2021). Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone. Contraception, 103 (4), 213 - 221. doi:10.1016/j.contraception.2021.01.001 |
Collée, J., MAWET, M., Tebache, L., Nisolle, M., & Brichant, G. (2021). Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments. Gynecological Endocrinology, 37 (10), 869-874. doi:10.1080/09513590.2021.1958310 |
Mawet, M., Perrier d'Hauterive, S., HENRY, L., Potorac, I., Kridelka, F., Nisolle, M., & Pintiaux, A. (2021). Restoration of Fertility in Patients with Spontaneous Premature Ovarian Insufficiency: New Techniques under the Microscope. Journal of Clinical Medicine, 10 (23). doi:10.3390/jcm10235647 |
Douxfils, J., Klipping, C., Duijkers, I., Kinet, V., Mawet, M., Maillard, C., Jost, M., Rosing, J., & Foidart, J.-M. (December 2020). Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters. Contraception, 102 (6), 396 - 402. doi:10.1016/j.contraception.2020.08.015 |
Mawet, M. (2020). Estetrol (E4), the fourth natural estrogen, molecular and clinical aspects [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/290573 |
GASPARD, U., Taziaux, M., Mawet, M., Jost, M., Gordenne, V., Coelingh Bennink, H. J. T., Lobo, R. A., Utian, W. H., & Foidart, J.-M. (August 2020). A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety. Menopause: the Journal of the Menopause Society, 27 (8), 848-857. doi:10.1097/GME.0000000000001561 |
Apter, D., Zimmerman, Y., Beekman, L., Mawet, M., Maillard, C., Foidart, J.-M., & Coelingh Bennink, H. J. T. (2017). Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control. European Journal of Contraception and Reproductive Health Care, 22 (4), 260-267. doi:10.1080/13625187.2017.1336532 |
Kluft, C., Zimmerman, Y., Mawet, M., Klipping, C., Duijkers, I. J. M., Neuteboom, J., Foidart, J.-M., & Bennink, H. C. (2017). Reduced hemostatic effects with drospirenone-based oral contraceptives containing estetrol vs. ethinyl estradiol. Contraception, 95 (2), 140-147. doi:10.1016/j.contraception.2016.08.018 |
Apter, D., Zimmerman, Y., Beekman, L., Mawet, M., Maillard, C., Foidart, J.-M., & Coelingh Bennink, H. (2016). Bleeding Pattern and Cycle Control With Estetrol-Containing Combined Oral Contraceptives: Results From a Phase II, Randomised, Dose-Finding Study (FIESTA). Contraception. doi:10.1016/j.contraception.2016.04.015 |
Palazzo, C., Karim, R., Furst, T., Pequeux, C., Tskitishvili, E., Mawet, M., Maillard, C., Foidart, J.-M., Evrard, B., & Piel, G. (25 October 2015). LIPOSOME ENCAPSULATING ESTETROL FOR THE TREATMENT OF ISCHEMIA DISEASES IN PREMATURE BABIES [Poster presentation]. 2015 AAPS Annual Meeting and Exposition, Orlando, FLA, United States. |
Palazzo, C., Karim, R., Pequeux, C., Tskitishvili, E., MAWET, M., Maillard, C., Foidart, J.-M., Evrard, B., & Piel, G. (02 June 2015). Liposome Encapsulating Estetrol For The Treatment Of Ischemia Diseases In Prematures Babies [Poster presentation]. Biomedica 2015, Genk, Belgium. |
Palazzo, C., Karim, R., MAWET, M., Maillard, C., Foidart, J.-M., Evrard, B., & Piel, G. (14 April 2015). LIPOSOME CONTAINING ESTETROL FOR THE TREATMENT OF ISCHEMIA DISEASES IN PREMATURE BABIES [Poster presentation]. 1st European Conference on Pharmaceutics, Reims, France. |
Duijkers, I. J. M., Klipping, C., Zimmerman, Y., Appels, N., Jost, M., Maillard, C., Mawet, M., Foidart, J.-M., & Bennink, H. J. T. C. (2015). Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study. European Journal of Contraception and Reproductive Health Care, 20 (6), 476-489. doi:10.3109/13625187.2015.1074675 |
Mawet, M., Maillard, C., Klipping, C., Zimmerman, Y., Foidart, J.-M., & Bennink, H. J. T. C. (2015). Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives. European Journal of Contraception and Reproductive Health Care, 20 (6), 463-475. doi:10.3109/13625187.2015.1068934 |
NEUPREZ, A., Delcour, J.-P., Fatemi, F., GILLET, P., Mawet, M., François, G., Bruyère, O., CRIELAARD, J.-M., Gosset, C., & Reginster, J.-Y. (2015). Development and validation of the French version of a tool assessing patient's expectations in lower limb osteoarthritis. Journal of Orthopaedics, 12, 46-57. doi:10.1016/j.jor.2014.06.002 |
Palazzo, C., Karim, R., MAWET, M., Maillard, C., Foidart, J.-M., Evrard, B., & Piel, G. (12 December 2014). Estetrol and cyclodextrin-estetrol loaded liposomes for the treatment of ischemia diseases in premature babies [Poster presentation]. Biopharmacy Day, Vlaardingen, Netherlands. |
Mawet, M., Nollevaux, F., Nizet, D., Wijzen, F., Gordenne, V., Tasev, N., Segedi, D., Marinescu, B., Enache, A., Parhomenko, V., Frankenne, F., & Foidart, J.-M. (2014). Impact of a New Levonorgestrel Intrauterine System, Levosert(®), on Heavy Menstrual Bleeding: Results of a One-Year Randomised Controlled Trial. European Journal of Contraception and Reproductive Health Care. doi:10.3109/13625187.2014.894184 |
NEUPREZ, A., Delcour, J., Fatemi, F., GILLET, P., MAWET, M., François, G., Bruyère, O., Crielaard, J.-M., Gosset, C., & Reginster, J.-Y. (2013). Développement et validation de la version française d'un questionnaire traitant des attentes des patients dans l'arthrose des membres inférieurs. Revue du Rhumatisme, 80 (S1), 181. |
EL SHAZLY, A., MOONEN, V., MAWET, M., Begon, D., HENKET, M., Arafa, M., LOUIS, R., Delvenne, P., & LEFEBVRE, P. (2011). IFN-gamma and TNF-alpha potentiate prostaglandin D2-induced human eosinophil chemotaxis through up-regulation of CRTH2 surface receptor. International Immunopharmacology, 11 (11), 1864-70. doi:10.1016/j.intimp.2011.07.017 |